Molecular BiologyBone ReportsPeer-reviewed
Early intermittent low-dose sclerostin antibody treatment promotes surface bone formation and reduces bone loss, but also decreases osteocyte apoptosis and mechanotransduction in ovariectomized rats: a pilot study
Sameer Naqvi, Wahaaj Ali, Hollie Allison…·Laoise M. McNamara
1 citation